Dr Chris Wincup asks Dr Filipa Farinha (London, UK) about her recent paper, which compares presentation, outcomes and predictors of survival in patients with membranous and proliferative lupus nephritis. They discuss the key findings, important implications for clinical practice, and Dr Farinha’s future research.
